The Centers of Disease Control and Prevention has launched an educational campaign aimed at informing health care providers about the health risks of diethylstilbestrol (DES) exposure.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.